A bill amending the 340B statute to explicitly require drug makers to unconditionally sell and deliver 340B drugs dispensed by contract pharmacies is expected to be introduced just before or during the 340B Coalition summer conference July 10-12 near Washington,
…
Two hospital groups separately urged Biden administration officials this month to not divert funding from non-340B hospitals and some 340B hospitals in order to repay other 340B hospitals for almost five years’ worth of illegal Medicare Part B drug payment
…
Federal health care officials can’t make a South Carolina health center obey their reading of the 340B patient definition for the same reason a federal appeals court said in January that the officials can’t force drug manufacturers to deliver 340B
…
Drug industry trade group Pharmaceutical Research and Manufacturers of America and drug manufacturer Bristol Myers Squibb have filed separate federal lawsuits to stop Medicare from negotiating the prices of some drugs, charging that it would impose unconstitutional price controls on
…
The six U.S. senators who asked Friday morning for ideas on ways to improve the 340B program elaborated on their reasons why in a news release that afternoon.
Sens. John Thune (R-S.D.), Debbie Stabenow (D-Mich.), Shelley Moore Capito (R-W.Va.), Tammy
…
The American Hospital Association has asked the U.S. Health Resources and Services Administration to resume letting hospitals dispense 340B drugs at offsite clinics that have not yet appeared on the hospital’s most recently filed Medicare cost report.
AHA asked HRSA
…
The Medicare Payment Advisory Commission is sticking by its long-standing recommendation that Medicare should pay less for Part B drugs furnished by 340B hospitals.
“We continue to believe that this approach is appropriate, and the specific level of payment reduction
…
The U.S. Health Resources and Services Administration has added two days to the next quarterly 340B registration period.
A HRSA spokesperson said Friday that Q3 registration for 340B covered entities, their child sites, and their contract pharmacies will begin July
…
Six Democratic and Republican U.S. senators this morning asked 340B drug pricing program stakeholders for input on “bipartisan policy solutions that would ensure the program has stability and oversight to continue to achieve its original intention of serving eligible patients.”
…
U.S. House Energy & Commerce Committee Chair Cathy McMorris Rodgers (R-Wash.) and Senate Finance Committee ranking Republican Mike Crapo (Idaho) are soliciting public input on what’s driving the increase in drug shortages, including whether or not the 340B drug pricing
…*Sign up for news summaries and alerts from 340B Report